US Patent:
20020045638, Apr 18, 2002
Inventors:
Yixian Zhang - Nanuet NY, US
Tammy Sadler - Chester NY, US
Philip Frost - Morris Township NJ, US
Lee Greenberger - Montclair NJ, US
International Classification:
A61K031/55
A61K031/4745
A61K031/135
US Classification:
514/291000, 514/217030, 514/649000
Abstract:
This invention provides a method of treating or inhibiting an estrogen receptor positive carcinoma in a mammal in need thereof, which comprises providing said mammal with an effective amount of a combination of a rapamycin and an antiestrogen.
